Skip Navigational Links
LISTSERV email list manager
LISTSERV - LIST.UVM.EDU
LISTSERV Menu
Log In
Log In
LISTSERV 17.5 Help - SCIENCE-FOR-THE-PEOPLE Archives
LISTSERV Archives
LISTSERV Archives
Search Archives
Search Archives
Register
Register
Log In
Log In

SCIENCE-FOR-THE-PEOPLE Archives

June 1999

SCIENCE-FOR-THE-PEOPLE@LIST.UVM.EDU

Menu
LISTSERV Archives LISTSERV Archives
SCIENCE-FOR-THE-PEOPLE Home SCIENCE-FOR-THE-PEOPLE Home
SCIENCE-FOR-THE-PEOPLE June 1999

Log In Log In
Register Register

Subscribe or Unsubscribe Subscribe or Unsubscribe

Search Archives Search Archives
Options: Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
News Flash, Vice President Gore endorses compulsory licensing and parallel imports of pharmaceuticals
From:
Aram Falsafi & Wendy Call <[log in to unmask]>
Reply To:
Science for the People Discussion List <[log in to unmask]>
Date:
Tue, 29 Jun 1999 20:18:22 -0400
Content-Type:
text/plain
Parts/Attachments:
text/plain (43 lines)
Please respond to [log in to unmask]
To:     Multiple recipients of list INFO-POLICY-NOTES <[log in to unmask]>
Subject:        News Flash, Vice President Gore endorses compulsory licensing and parallel imports of pharmaceuticals



Subject:    News Flash, Vice President Gore endorses compulsory licensing and parallel imports of pharmaceuticals

Date: Mon, 28 Jun 1999 18:47:34 -0400
From: James Love <[log in to unmask]>
Organization:  http://www.cptech.org

Today the Congressional Black Caucus made available copies of an exchange of letters between James Clyburn, the Chairman of the Congressional Black Caucus (written on June 24) and Vice President Al Gore (written on June 25), regarding US trade policy toward South Africa.

The Clyburn letter is one page and the Gore letter is 2.25 pages.

In my opinion, the most important part of the Vice President's letter is the following statement in the second paragraph.  It reads:


   I want you to know from the start that I support South Africa's efforts to enhance health care for its people-- including efforts to engage in compulsory licensing and parallel importing of pharmacueticals--so long as they are done in a way consistent with international agreements.

     (Letter to Representative James E. Clyburn, June 25, 1999)


This statement seems to suggest a major change in US government policy.  To put this into perspective, right now the US government has trade actions against 11 countries for parallel importing (copyright and pharmaceutical cases) and 14 countries on compulsory licensing.  We have a special "out-of-cycle" review of South Africa on both compulsory licensing and parallel importing of pharmaceuticals, and another out-of-cycle review against Israel on both
issues.

On the other hand, a word of caution is recommended.  The letter continues to frame this in terms of "so long as they are done in a way consistent with international agreements," as if, for example, there is any doubt about the legal basis for parallel imports, or as if there is any doubt about the South African government's  often expressed willingness to abide by WTO Article 31 TRIPS rules on compulsory licensing.  Moreover, the remainder of the letter provides a highly selective and self serving
account of the Vice President's actions, leaving out key details such as the withholding of tariff reductions over the pharmacuetical dispute, the subequent decision by the Administration to tie the availability to the outcome of negotiations between drug company executives and the South African Ministery of Health over its Medicines Act, and the recent April 30, 1999 decision to begin a new round of trade pressures against South Africa, including the Special out-of-cycle review to be concluded in
September.

Tonight there is a much anticipated demonstration against the Vice President at Philadelphia fund raiser, where these issues will be raised yet again.

More on this later.

Jamie Love


--
James Love, Director, Consumer Project on Technology
I can be reached at [log in to unmask], by telephone 202.387.8030,
by fax at 202.234.5176. CPT web page is http://www.cptech.org

ATOM RSS1 RSS2

LIST.UVM.EDU CataList Email List Search Powered by LISTSERV